Doubling rate of coronavirus infection in Mumbai crosses 100 days for first time

▴ Doubling rate of coronavirus infection in Mumbai crosses 100 days for first time
At last some good news for Mumbaikars

In a positive development, the doubling rate of coronavirus infection in Mumbai has crossed 100 days for the first time.

The Municipal Corporation of Greater Mumbai, in a statement, said that the doubling rate now stands at 102.

Our correspondent reports, Mumbai’s civic chief Iqbal Singh Chahal has thanked Mumbaikars for their disciplined efforts to contain the coronavirus pandemic.

In a statement, Mumbai’s civic body has informed that the programmes like ‘Chase the Virus’, ‘Mission Zero’ and the four-fold technique of tracing, tracking, testing and treating have yielded desired results.

While the first confirmed case of COVID-19 was reported on 11th March in the financial capital and the doubling rate stood at three days later that month, the doubling rate has increased to 102 days today.

The statement says that the door to door survey and the awareness campaign conducted under the ‘My Family,

My Responsibility’ programme played a huge role in identifying co-morbid patients and protecting them from the virus.

Right from setting up fever clinics in the initial days to running mobile dispensaries across all the 24 wards of Mumbai, the city has managed to achieve a recovery rate of 88 percent.

While the city continues to record around one thousand new cases every day, the number of active patients currently remains below 20,000.

Meanwhile, India has sustained its trend of maintaining the active cases below the 7.5 lakh mark for the 2nd successive day. 61,775 recoveries have been registered in the last 24 hours in the country whereas the new confirmed cases are only 54,044. This is when 10,83,608 tests have been conducted in the last 24 hours in the country.

The national Case Fatality Rate (CFR) has fallen to 1.51% today. The Centre has advised States/UTs to aim at bringing down the CFR to below 1%. Presently 14 States/UTs are reporting Case Fatality Rate less than 1%. India’s total recoveries stand at 67,95,103 today. The higher number of single-day recoveries has resulted in a continuous increase in the national recovery rate, which is fast approaching 89% (88.81%). 77% of the new recovered cases are observed to be concentrated in 10 States/UTs.

Karnataka outnumbered Maharashtra in new recovered cases with more than 8,500 new recoveries. Maharashtra and Kerala both contribute more than 7,000 to the new recoveries. 54,044 new cases were registered in the last 24 hours in the country. 78% of these are concentrated in ten States/UT. Maharashtra contributed more than 8,000 to the new cases. Karnataka and Kerala, both contributed more than 6,000. 717 deaths have been registered in the past 24 hours. 82% of new deaths are reported from 10 States and UTs. 29% of deaths reported yesterday are from Maharashtra with 213 deaths followed by Karnataka with 66 deaths.

Tags : #MumbaiLatestCovidNewsOct22 #IndiaCovidNewsUpdateOct22 #IqbalSinghChahal #NationalCaseFatalityRateOct22 #BMC

About the Author


Team Medicircle

Related Stories

09 Nov

Full dose of Zydus Cadila's Covid vaccine at Rs 1,128

Zycov-D is the first DNA Plasmid vaccine

View
21 Aug

First needle less COVID vaccines for children and adult above 12 years got approval for EUA

Zydus Cadila’s ZyCov-D, Covid vaccine got Emergency Use Authorization for children and adults 12 years and above

View
26 Jun

Country soon to get world’s first DNA-plasmid vaccine by Zydus Cadilla: Chairman COVID-19 NTAGI

Zydus Cadila vaccine to be available by September

View
22 Jun

Zydus and Bayer announce continuity of their successful Joint Venture

Bayer Zydus Pharma has been a successful partnership combining Bayer’s scientific expertise and commercialization of novel products backed by Cadila Healthcare’s strong India presence.

View
19 Jun

European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European Union.

View
06 Jan

Top Ten Pharma Companies of India : January 2021

Top ten pharma stocks January 2021

View
30 Dec

Zydus announces the approval of Saroglitazar Mg for the treatment of Non-Alcoholic fatty Liver disease in India

About 25 to 30% of Indian population suffers from NALD

View
12 Dec

India readies for 600 million COVID vaccine jabs; to use standard cold storage - top government expert

India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six to eight months through conventional cold chain systems.

View
08 Dec

India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan

India is among the top ten countries in the world with respect to the number of patents filed.

View
07 Dec

Pfizer seeks emergency use authorization for its COVID-19 vaccine in India

India to soon have the Covid-19 vaccine from Serum and Pfizer

View

-Advertisements-




Trending Now

Teenagers Are Losing Friends While Chasing Perfection: Here’s WhyMarch 13, 2025
Your Desk Job is Destroying Your Mind: Here’s How to Fight BackMarch 13, 2025
Wow! Momo Disrupts FMCG Cup Noodles Market with 'Desi-Asian Flavours' – A First in IndiaMarch 13, 2025
How India’s Kidney Health Crisis is Growing UnnoticedMarch 13, 2025
Stuck Between the Snooze Button and the Hustle: Entrepreneurs Struggle to Get Quality SleepMarch 13, 2025
Can Coffee Keep You Steady on Your Feet? New Study Reveals the TruthMarch 13, 2025
NephroPlus Sets Guinness World Record & India Book of Records Title for Largest Kidney Health Screening DriveMarch 12, 2025
India Choosing to Eat Healthy; Order Volumes Up by 60% for Nutritional ProductsMarch 12, 2025
Amrita students win first prize at DecodeX 2025 hackathonMarch 12, 2025
Why Millions Are Losing Their Sight to Glaucoma And How You Can Prevent ItMarch 12, 2025
Çelebi India Ranks 3rd Worldwide in Ground Handling Performance for Turkish CargoMarch 12, 2025
Advancing Road Safety Through Clear Vision: VARS 4.0 Sets Bold AgendaMarch 12, 2025
The Deadly Cost of the “Perfect Body”: When Diet Trends Turn FatalMarch 12, 2025
Lighthouse Canton’s LC GenInnov Global Innovation Fund Secures Investment from Kotak Mahindra Asset ManagementMarch 11, 2025
TTK Prestige Revolutionizes Cooking with Innovative AirFlip Two-in-One Air Fryer and GrillMarch 11, 2025
Rewriting Immunology: The Discovery That Could Replace Traditional AntibioticsMarch 11, 2025
Is Your Cooking Oil Poisoning You? The Truth About Seed OilsMarch 11, 2025
Think Before You Bite: How Fatty Foods Can Trigger Brain Damage in Just 3 DaysMarch 11, 2025
Ditch the Pills: The Secret to Beating Insomnia is in Your WorkoutMarch 11, 2025
The University of Tasmania invites applications for Master of Public HealthMarch 11, 2025